Bernadette Mitchell
Overview
Explore the profile of Bernadette Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serhal S, Krass I, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, et al.
J Am Pharm Assoc (2003)
. 2024 Sep;
65(1):102252.
PMID: 39326844
Background: Evidence-based asthma management services have been tested in Australian community pharmacies for over 2 decades and have been well received by patients but are not retained in practice. The...
2.
Krass I, Twigg M, Mitchell B, Wilson F, Mohebbi M, Trinder P, et al.
BMC Health Serv Res
. 2023 Dec;
23(1):1337.
PMID: 38041094
Background: The Pharmacy Diabetes Screening Trial (PDST) evaluated three approaches to screening for undiagnosed type 2 diabetes mellitus (T2DM) in community pharmacy: (1) paper-based risk assessment (AUSDRISK) alone; and AUSDRISK...
3.
Krass I, Carter R, Mitchell B, Mohebbi M, Shih S, Trinder P, et al.
Diabetes Res Clin Pract
. 2023 Feb;
197:110566.
PMID: 36738834
Aims: To compare the effectiveness of three pharmacy-based screening methods for type 2 diabetes (T2DM): (1) risk assessment (AUSDRISK) alone (Group A); AUSDRISK followed by a point of care test...
4.
Serhal S, Mitchell B, Krass I, Emmerton L, Bereznicki B, Bereznicki L, et al.
Res Social Adm Pharm
. 2022 Apr;
18(9):3656-3668.
PMID: 35379559
Background: An evidence-based randomized controlled trial for a novel Pharmacy Asthma Service was tested in 3 Australian states. Positive asthma outcomes were achieved after the 12-month intervention, albeit in both...
5.
Serhal S, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, Bereznicki L, et al.
J Am Pharm Assoc (2003)
. 2022 Mar;
62(4):1260-1269.e2.
PMID: 35283066
Background: Evaluating pharmacy services from the perspective of the end user-patients-is imperative for ensuring the sustainability of services. Objectives: This study evaluated patient feedback regarding an evidence-based community pharmacist-delivered Pharmacy...
6.
Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, Bereznicki B, et al.
Front Pharmacol
. 2022 Jan;
12:798263.
PMID: 35024035
Building on lessons learnt from evidence-based community pharmacy asthma management models, a streamlined and technology supported Pharmacy Asthma Service (PAS) was developed to promote the integration of the service into...
7.
Serhal S, Saini B, Bosnic-Anticevich S, Krass I, Emmerton L, Bereznicki B, et al.
Am J Pharm Educ
. 2021 Aug;
86(4):8633.
PMID: 34400397
To provide optimal asthma care, community pharmacists must have advanced, contemporary knowledge, and the skills to translate that knowledge into practice. The development and evaluation of an innovative multi-mode education...
8.
Fathima M, Bawa Z, Mitchell B, Foster J, Armour C, Saini B
Int J Chron Obstruct Pulmon Dis
. 2021 Mar;
16:519-533.
PMID: 33688177
Purpose: To evaluate the effectiveness of a pilot community pharmacy care model for patients with chronic obstructive pulmonary disease (COPD) to improve: 1) inhaler technique; 2) medication adherence; and 3)...
9.
Siu A, Krass I, Mitchell B, McNamara K
Res Social Adm Pharm
. 2021 Jan;
17(9):1606-1613.
PMID: 33414090
Introduction: Community pharmacists are increasingly providing a range of professional health services. Whilst research provides evidence of their benefits, knowledge translation into practice has been challenging both in Australia and...
10.
Krass I, Carter R, Mitchell B, Mohebbi M, Shih S, Trinder P, et al.
BMJ Open
. 2017 Dec;
7(12):e017725.
PMID: 29284715
Introduction: With the rising prevalence of type 2 diabetes in Australia, screening and earlier diagnosis is needed to provide opportunities to intervene with evidence-based lifestyle and treatment options to reduce...